sulotroban has been researched along with dazmegrel in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dack, KN; Dickinson, RP; Long, CJ; Steele, J | 1 |
| Ercan, ZS; Sindel, S; Türker, R | 1 |
2 other study(ies) available for sulotroban and dazmegrel
| Article | Year |
|---|---|
Thromboxane modulating agents. 3. 1H-imidazol-1-ylalkyl- and 3-pyridinylalkyl-substituted 3-[2-[(arylsulfonyl)amino]ethyl]benzenepropanoic acid derivatives as dual thromboxane synthase inhibitor/thromboxane receptor antagonists.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Administration, Oral; Animals; Dogs; Drug Design; Enzyme Inhibitors; Imidazoles; Microsomes; Molecular Structure; Muscle Contraction; Phenylpropionates; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyridines; Rats; Receptors, Thromboxane; Structure-Activity Relationship; Thromboxane-A Synthase; Thromboxanes | 1997 |
Possible thromboxane A2 mediated effect of angiotensin II in the rabbit isolated perfused kidney.
Topics: Angiotensin II; Animals; Female; Imidazoles; In Vitro Techniques; Kidney; Male; Norepinephrine; Perfusion; Rabbits; Sulfonamides; Thromboxane A2; Thromboxane-A Synthase; Urine | 1991 |